Literature DB >> 16148260

Prevalence and size of directly detected patent foramen ovale in migraine with aura.

M Schwerzmann1, K Nedeltchev, F Lagger, H P Mattle, S Windecker, B Meier, C Seiler.   

Abstract

BACKGROUND: Transcranial contrast Doppler studies have shown an increased prevalence of right-to-left shunts in patients with migraine with aura compared with controls. The anatomy and size of these right-to-left shunts have never been directly assessed.
METHODS: In a cross-sectional case-control study, the authors performed transesophageal contrast echocardiography in 93 consecutive patients with migraine with aura and 93 healthy controls.
RESULTS: A patent foramen ovale was present in 44 (47% [95% CI 37 to 58%]) patients with migraine with aura and 16 (17% [95% CI 10 to 26%]) control subjects (OR 4.56 [95% CI 1.97 to 10.57]; p < 0.001). A small shunt was equally prevalent in migraineurs (10% [95% CI 5 to 18%]) and controls (10% [95% CI 5 to 18%]), but a moderate-sized or large shunt was found more often in the migraine group (38% [95% CI 28 to 48%] vs 8% [95% CI 2 to 13%] in controls; p < 0.001). The presence of more than a small shunt increased the odds of having migraine with aura 7.78-fold (95% CI 2.53 to 29.30; p < 0.001). Besides patent foramen ovale prevalence and shunt size, no other echocardiographic differences were found between the study groups. Headache and baseline characteristics did not differ in migraine patients with and without shunt.
CONCLUSIONS: Nearly half of all patients with migraine with aura have a right-to-left shunt due to a patent foramen ovale. Shunt size is larger in migraineurs than controls. The clinical presentation of migraine is identical in patients with and without a patent foramen ovale.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148260     DOI: 10.1212/01.wnl.0000179800.73706.20

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  47 in total

1.  The relationship between migraine and right-to-left shunt in children.

Authors:  Sevcan Sarısoy; Ömer Faruk Aydın; Metin Sungur; Ilkay Koray Bayrak; Servet Aker; Hamit Özyürek; Haydar Ali Taşdemir; Kemal Baysal
Journal:  Eur J Pediatr       Date:  2010-09-28       Impact factor: 3.183

2.  Prevalence and characteristics of right-to-left shunt in migraine with aura: a survey on 120 Italian patients.

Authors:  L Caputi; Domenico D'Amico; S Usai; L Grazzi; E A Parati; G Bussone
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

Review 3.  Migraine and patent foramen ovale.

Authors:  Jessica Ailani
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

4.  Prevalence of cardiac right left shunts in migraine: a population-based case-control study.

Authors:  Michael Küper; Kasja Rabe; Dagny Holle; Irini Savidou; Peter Dommes; Markus Frings; Hans Christoph Diener; Zaza Katsarava
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

5.  Coexistence of acute myocardial infarction with normal coronary arteries and migraine with aura in a female patient.

Authors:  Umut Celikyurt; Goksel Kahraman; Ender Emre
Journal:  World J Cardiol       Date:  2011-07-26

Review 6.  Migraine-associated risks and comorbidity.

Authors:  H C Diener; M Küper; T Kurth
Journal:  J Neurol       Date:  2008-09-30       Impact factor: 4.849

Review 7.  Migraine and cerebrovascular disease: still a dangerous connection?

Authors:  Elio Clemente Agostoni; Marco Longoni
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

8.  Patent foramen ovale and migraine: no reason to intervene.

Authors:  Hans-Christoph Diener
Journal:  J Headache Pain       Date:  2007-02       Impact factor: 7.277

Review 9.  The migraine association with cardiac anomalies, cardiovascular disease, and stroke.

Authors:  Todd J Schwedt
Journal:  Neurol Clin       Date:  2009-05       Impact factor: 3.806

10.  Stroke and migraine.

Authors:  Jesse Weinberger
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.